Development and Validation of Targeted Gene Sequencing Panel Based Companion Diagnostic for Korean Patients with Solid Tumors

SIMPLE SUMMARY: We have developed and analytically validated the Korean Pan-cancer Companion Diagnostic (CDX) Panel to apply targeted anticancer drugs to Korean patients based on the molecular characteristics of tumors using tumor samples without matched patient normal samples. The panel included 31...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Byung-Joo, Lee, Woo Seung, Seo, Myung-Eui, Lee, Kye-Hwa, Jeong, Seung-Yong, Ku, Ja-Lok, Kim, Yeul Hong, Shin, Sang-Won, Kim, Ju Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534153/
https://www.ncbi.nlm.nih.gov/pubmed/34680263
http://dx.doi.org/10.3390/cancers13205112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534153/
https://www.ncbi.nlm.nih.gov/pubmed/34680263
http://dx.doi.org/10.3390/cancers13205112

Ejemplares similares